Solesence, Inc. SLSN
Package Goods/Cosmetics · data as of November 13, 2026
Solesence, Inc. (SLSN) is a consumer discretionary company listed in the US with a market value of about $107M. In the twelve months to September 30, 2026 it had revenue of $61M and net income of $3M, a net margin of 4.5%.
Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (1/5).
Key numbers: a P/E of 50.7, a price to free cash flow of 13.0, 5-year revenue growth of 29% a year, a 5-year average ROIC of -1%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 59% below the current price.
About Solesence
Solesence is listed in the US and classified in package goods/cosmetics. Revenue went from $10M in 2014 to $62M in 2025, growth of about 18.1% a year. It was profitable in 4 of the last 10 years in our data. Its share count rose by 196% over three years (dilution for shareholders). It spends 7% of revenue on research and development.
Score: 2.2 / 5
Checks passed
- P/FCF below 20
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- ROE above 15%
- Positive free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $61M | $62M | $52M | $37M | $37M | $29M | $17M | $13M | $14M | $12M | $11M |
| Net income | $3M | $3M | $1M | -$5M | -$3M | $2M | $989000 | -$3M | -$2M | -$789000 | -$1M |
| Free cash flow | $8M | -$11M | -$3M | -$3M | -$4M | $447000 | -$3M | -$4M | -$2M | -$1M | -$369000 |
| EPS (diluted) | $0.04 | $0.04 | $0.02 | $-0.10 | $-0.10 | $0.10 | $0.06 | $-0.16 | $-0.12 | $-0.06 | $-0.08 |
| Net margin | 4.5% | 4.5% | 2.1% | -13.2% | -7.0% | 7.9% | 5.8% | -24.0% | -14.7% | -6.3% | -11.9% |
| ROIC | — | 8.8% | 8.0% | -22.1% | -11.3% | 11.4% | 18.7% | -50.2% | -146.2% | -21.9% | -35.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is Solesence’s P/E ratio?
About 50.7, based on the last twelve months of diluted earnings per share.
Is Solesence stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 59% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Solesence pay a dividend?
Not currently.
Is Solesence a good stock to buy?
We do not give buy or sell advice. Solesence scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.